miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Oral squamous cell carcinoma (OSCC) progression is linked to aberrant microRNA (miRNA) expression.
• MiRNAs play crucial roles in regulating cellular processes relevant to cancer development.

Purpose of the Study:

• To investigate the role of miR-182-5p in OSCC.
• To identify the downstream target of miR-182-5p in OSCC.
• To explore the therapeutic potential of targeting the miR-182-5p pathway in OSCC.

Main Methods:

• Quantification of miR-182-5p expression in OSCC tissues and cell lines using RT-PCR.
• Assessment of OSCC cell proliferation via colony formation, CCK-8, Ki-67 assays, and nude mouse xenografts.
• Identification of miR-182-5p targets using western blotting, RT-PCR, and luciferase assays.
• Analysis of patient survival in relation to CAMK2N1 expression.

Main Results:

• miR-182-5p was significantly upregulated in OSCC samples and promoted OSCC cell proliferation and growth.
• miR-182-5p directly targets CAMK2N1, which acts as a tumor suppressor in OSCC.
• Downregulation of miR-182-5p restored CAMK2N1 expression and suppressed OSCC cell proliferation.
• miR-182-5p inhibited the activation of key signaling pathways including AKT, ERK1/2, and NF-κB.

Conclusions:

• The miR-182-5p-CAMK2N1 axis is a critical regulator of OSCC cell proliferation.
• Targeting the miR-182-5p-CAMK2N1 pathway presents a promising therapeutic strategy for oral squamous cell carcinoma.